{
  "id": 7531306,
  "title": "Contineum, J&J's drug fails in mid-stage depression trial",
  "url": "https://urgent.news/2026/09/15/contineum-j-js-drug-fails-in-mid-stage-depression-trial",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-15T10:29:00.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/depression-drug-from-contineum-and-jj-fails-in-mid-stage-study/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Contineum Therapeutics and Johnson & Johnson’s oral M1 receptor inhibitor has missed its second mid-stage study in a year, this time in major depressive disorder. The drug, called PIPE-307 or JNJ-5120, failed to show statistically ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}